Frontlight ResearchEarly access
Asthma trials in Serbia
5 of 5 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2)
- Where
- Belgrade, Kamenitz, Kragujevac, Novi Sad, Zaječar
- Age
- 12 years to 80 years
- People
- 786 worldwide
- Run by
- Generate Biomedicines
See details and how to joinNCT07359846 - Phase 2Not yet taking people in SerbiaA Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma
- Where
- Belgrade, Novi Sad
- Age
- 4 years to 11 years
- People
- 69 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07525375 · EU 2025-524914-26-00 - Phase 2Taking peopleA Long-term Study of KT-621 Administered Orally to Participants With Asthma Previously Enrolled in a KT-621 Asthma Study
- Where
- Kamenitz, Užice
- Age
- 18 years and over
- People
- 264 worldwide
- Run by
- Kymera Therapeutics, Inc.
See details and how to joinNCT07677059 - Phase 2Taking peopleA Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
- Where
- Belgrade, Kamenitz, Užice
- Age
- 18 years to 75 years
- People
- 264 worldwide
- Run by
- Kymera Therapeutics, Inc.
See details and how to joinNCT07323654 - Phase 2Taking peopleTherapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma
- Where
- Belgrade, Kragujevac, Niš, Novi Sad, Sremska Mitrovica, Užice, Valjevo
- Age
- 18 years to 75 years
- People
- 780 worldwide
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07301736 · EU 2025-521456-35-00